Related Experiment Videos
Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients
Takashi Shigematsu1, Takashi Kono, Kenichi Satoh
1Division of Nephrology and Hypertension, Jikei University School of Medicine, Japan.
Insights
Controlling phosphate levels is crucial for preventing vascular calcification in end-stage renal disease (ESRD) patients. High phosphate stimulates smooth muscle cells to deposit calcium, worsening arteriosclerosis.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality in end-stage renal disease (ESRD) patients.
- Vascular calcification is a prominent feature of arteriosclerosis in ESRD, contributing to CVD.
- Identifying modifiable factors for vascular calcification is critical for improving patient outcomes.
Purpose of the Study:
- To investigate factors promoting vascular calcification in ESRD patients.
- To explore the role of phosphate overload in calcium deposition within human vascular smooth muscle cells (hVSMCs).
Main Methods:
- Clinical analysis of ESRD patients using the aortic arch calcification score (AACS) from chest X-rays.
- In vitro cell culture experiments using hVSMCs from ESRD patients exposed to varying phosphate concentrations.
Main Results:
- Significant factors for vascular calcification (AACS) included Ca x Pi, age, dialysis duration, blood pressure, smoking, and diabetes mellitus.
- Serum phosphate concentration (Ca x Pi) emerged as a correctable factor for vascular calcification.
- Phosphate overload stimulated hVSMCs to secrete extracellular matrix with high calcium affinity, accelerating calcium deposition.
Conclusions:
- Control of serum phosphate concentration is a key target for reducing vascular calcification in ESRD.
- Phosphate excess may directly stimulate vascular smooth muscle cells, promoting arterial calcification.
- Managing phosphate levels is essential for preventing vascular calcification and associated cardiovascular complications in ESRD.
Abstract:
Cardiovascular disease is a major problem in end-stage renal disease (ESRD) patients, with calcification being one of the conspicuous features of arteriosclerotic vessels. In the present study, clinical analysis and in vitro cell culture were used to investigate factors promoting vascular calcification in ESRD patients. The aortic arch calcification score (AACS) was the method used to estimate vascular calcification by evaluation of the simple posterior-anterior view chest X-rays. Factors that relate significantly to vascular calcification and the AACS are the Ca x Pi, age, dialysis period, blood pressure, smoking and diabetes mellitus, but not total cholesterol or triglyceride. The Ca x Pi, which depends on the serum phosphate concentration, is the only specific factor with the possibility for correction in ESRD patients, and so control of serum phosphate concentration is an important factor for reducing vascular calcification. The effects of phosphate overload on calcium deposition in human vascular smooth muscle cells (hVSMCs) using a primary cell culture system were also investigated. hVSMCs were harvested from the radial artery in ESRD patients and it was found that they could secrete extracellular matrix with a high affinity for calcium in a high phosphate medium (Pi=5.4 mg/dl). Therefore, phosphate overload might stimulate the hVSMCs to accelerate the calcium deposition in ESRD patients. These results suggest that the control of phosphate excess is important for prevention of calcium deposition on arteriole walls in ESRD patients.